AbbVie (ABBV) director Susan Quaggin receives 1,118 restricted stock units grant

Rhea-AI Filing Summary

Quaggin Susan E reported acquisition or exercise transactions in this Form 4 filing.

AbbVie Inc. director Susan E. Quaggin received an award of 1,118 restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program. The units will be settled in an equal number of AbbVie common shares upon the earlier of her separation from service, death, or a change in control as defined in the program.

Following this grant, she directly holds 3,643 shares of AbbVie common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Quaggin Susan E

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.01 par value	1,118	$0.00	--

Holdings After Transaction: Common Stock, $0.01 par value — 3,643 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock units granted: 1,118 units Shares held after transaction: 3,643 shares Grant price per share: $0.00 per share

3 metrics

Restricted stock units granted 1,118 units Grant to director Susan E. Quaggin on May 8, 2026

Shares held after transaction 3,643 shares Direct AbbVie common stock holdings post-grant

Grant price per share $0.00 per share Compensation award, not an open-market purchase

Key Terms

restricted stock units, AbbVie Amended and Restated 2013 Incentive Stock Program, change in control

3 terms

restricted stock units financial

"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AbbVie Amended and Restated 2013 Incentive Stock Program financial

"awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program")"

change in control financial

"on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Quaggin Susan E

(Last) (First) (Middle)

1 N. WAUKEGAN ROAD

(Street)

NORTH CHICAGO ILLINOIS 60064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AbbVie Inc. [ ABBV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 par value	05/08/2026		A		1,118(1)	A	$0	3,643	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

	/s/ T.O. Odutayo, attorney-in-fact for Susan E. Quaggin	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AbbVie (ABBV) report for Susan E. Quaggin?

AbbVie reported that director Susan E. Quaggin received 1,118 restricted stock units as a grant. These units were awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program and will convert into AbbVie common shares at specific future events.

How many AbbVie shares does Susan E. Quaggin hold after this Form 4 transaction?

After this transaction, Susan E. Quaggin directly holds 3,643 AbbVie common shares. This figure includes the impact of the 1,118 restricted stock units granted, which are scheduled to be paid out in shares upon certain future triggering events.

What are the terms of the restricted stock units granted to AbbVie director Susan E. Quaggin?

The 1,118 restricted stock units will be paid one-for-one in AbbVie common stock. Payment occurs on the earlier of the director’s separation from service, death, or a change in control, as defined in the AbbVie Amended and Restated 2013 Incentive Stock Program.

Did Susan E. Quaggin buy or sell AbbVie (ABBV) shares in this Form 4?

She did not buy or sell shares on the open market in this filing. Instead, she acquired 1,118 restricted stock units as a grant, which is categorized as a compensation-related award rather than a market purchase or sale.

Under which plan were Susan E. Quaggin’s AbbVie restricted stock units granted?

The restricted stock units were granted under the AbbVie Amended and Restated 2013 Incentive Stock Program. This plan governs the award terms, including payment in AbbVie common stock and the events that trigger settlement of the units.